Скачать или смотреть Webinar on HCV treatment access for low- and middle-income countries - 26 May 21

10 years left to eliminate viral hepatitis – what now, what next for uptake in hepatitis C treatment in low- and middle-income countries?

With 10 years left to reach hepatitis elimination, this session, hosted by the World Health Organization, Unitaid and the Medicines Patent Pool on the sidelines of the seventy-fourth World Health Assembly, focused on access to hepatitis C treatment in low- and middle-income countries, and explored insights into key aspects of successful plans from countries and partners for tackling viral hepatitis.

Introduction by Charles Gore - moderator, Executive Director, MPP

Presentations from
Dr Meg Doherty - Director of Global HIV, Hepatitis and STIs Programmes, WHO
Dr Philippe Duneton - Executive Director, Unitaid
Dr Sabin Nsanzimana - Director General, Rwanda Biomedical Centre

Panel discussion with:
Professor Olga Golubovskaya - Head at the Department of Infectious Diseases, Bogomolets National Medical University of Kiev, Ukraine
Dr Huma Qureshi - Gastroenterologist and National focal point hepatitis, Pakistan
Karin Timmermans - Technical Manager, Unitaid
Danjuma Adda - President-elect, World Hepatitis Alliance
Sonjelle Shilton - Deputy Head HCV Access, FIND, the global alliance for diagnostics
Sandra Nobre - Head of Business Development, MPP
Craig McClure - Senior Director, Viral Hepatitis, Clinton Health Access Initiative (CHAI)

Please note that this session is part of the Hepatitis Online Series which are three one-hour live sessions bringing together key contributions in the hepatitis space from which to learn from.

More information: https://medicinespatentpool.org/news-...